| 1 |
9287313 | Multiple dimeric forms of human CD69 result from differential addition of N-glycans to typical (Asn-X-Ser/Thr) and atypical (Asn-X-cys) glycosylation motifs. | 1997 Sep 12 |
1 |
| 2 |
7964477 | Triggering of human monocyte activation through CD69, a member of the natural killer cell gene complex family of signal transducing receptors. | 1994 Nov 1 |
1 |
| 3 |
8100776 | Molecular characterization of the early activation antigen CD69: a type II membrane glycoprotein related to a family of natural killer cell activation antigens. | 1993 Jul |
1 |
| 4 |
1315360 | Preferential involvement of a phospholipase A2-dependent pathway in CD69-mediated platelet activation. | 1992 May 1 |
1 |
| 5 |
1710239 | CD69 in resting and activated T lymphocytes. Its association with a GTP binding protein and biochemical requirements for its expression. | 1991 Jun 15 |
1 |
| 6 |
2388032 | CD69 is expressed on platelets and mediates platelet activation and aggregation. | 1990 Sep 1 |
1 |
| 7 |
2501389 | T cell activation via Leu-23 (CD69). | 1989 Aug 15 |
1 |
| 8 |
3264302 | The 28-kDa/32-kDa activation antigen EA 1. Further characterization and signal requirements for its expression. | 1988 Dec 15 |
1 |
| 9 |
2946796 | Human T cell activation. III. Rapid induction of a phosphorylated 28 kD/32 kD disulfide-linked early activation antigen (EA 1) by 12-o-tetradecanoyl phorbol-13-acetate, mitogens, and antigens. | 1986 Dec 1 |
2 |